Help us determine the efficacy of an investigational vaccine for RSV.
RSV
Respiratory Syncytial Virus (RSV)
STUDY INFORMATION
MedPharmics is currently doing a study on a research vaccine in adults to prevent a viral infection, known as Respiratory Syncytial Virus, sometimes called RSV. In this placebo-controlled study, there is a 4 in 5 chance of receiving investigational vaccine and 1 in 5 chance of receiving placebo.
MEDICAL CONDITION
Healthy
GENDER
All
COMPENSATION
You may be compensated for time and travel
LOCATION
Metairie, LA / Albuquerque, NM / Phoenix, AZ / Gulfport, MS
ENROLLMENT
Active
AGE RANGE
12-59 months, 18-49 y/o, and 65-79 y/o
COMMITMENT
6-10 months
NUMBER OF VISITS
9-12 visits, 1-4 calls